XML 121 R92.htm IDEA: XBRL DOCUMENT v3.22.1
Share-based payments - Valuation of Options (Details)
€ / shares in Units, € in Thousands
12 Months Ended
Dec. 31, 2021
$ / shares
Dec. 31, 2021
EUR (€)
Y
€ / shares
Dec. 31, 2020
$ / shares
Dec. 31, 2020
EUR (€)
Y
Dec. 31, 2019
EUR (€)
Options          
Key assumptions used to derive other equity instruments value          
Exercise price (USD)     $ 11.60    
Share price at grant date (USD)     11.05    
Volatility (%)       75.00%  
Riskfree interest rate (%)       0.80%  
Dividend yield (%)       0.00%  
Expected contractual life (years) | Y       10  
Weighted average fair value (USD)     6.20    
Options | Mr. Modig and Mr. Sheldon          
Key assumptions used to derive other equity instruments value          
Exercise price (USD) $ 9.92        
Share price at grant date (USD) 10.01        
Volatility (%)   75.00%      
Riskfree interest rate (%)   1.70%      
Dividend yield (%)   0.00%      
Expected contractual life (years) | Y   10.0      
Weighted average fair value (USD) 7.86        
Options | Mr, Modig          
Key assumptions used to derive other equity instruments value          
Exercise price (USD) 14.00        
Share price at grant date (USD) 10.01        
Volatility (%)   75.00%      
Riskfree interest rate (%)   1.70%      
Dividend yield (%)   0.00%      
Expected contractual life (years) | Y   10      
Weighted average fair value (USD) 7.45        
Options | Mr. Kim          
Key assumptions used to derive other equity instruments value          
Exercise price (USD) 11.60        
Share price at grant date (USD) 10.80        
Volatility (%)   75.00%      
Riskfree interest rate (%)   1.70%      
Dividend yield (%)   0.00%      
Expected contractual life (years) | Y   9      
Weighted average fair value (USD) 8.21        
Performance Based RSUs          
Key assumptions used to derive other equity instruments value          
Share price at grant date (USD)     12.54    
Volatility (%)       88.00%  
Dividend yield (%)       0.00%  
Weighted average fair value (USD)     8.23    
Performance Based RSUs | Minimum          
Key assumptions used to derive other equity instruments value          
Riskfree interest rate (%)   1.90%   0.20%  
Expected contractual life (years) | Y   10   12.08  
Performance Based RSUs | Maximum          
Key assumptions used to derive other equity instruments value          
Riskfree interest rate (%)       0.30%  
Expected contractual life (years) | Y       13.08  
Virtual share option program 2017 (Cash settled)          
Expenses arising from share-based payment transactions          
Expenses arising from cash-settled share-based payment transactions | €         € 5,118
Virtual share option program 2016 (Cash-settled)          
Expenses arising from share-based payment transactions          
Expenses arising from cash-settled share-based payment transactions | €         596
Equity share option 2017 and 2019          
Expenses arising from share-based payment transactions          
Expenses arising from cash-settled share-based payment transactions | €         5,714
Expenses arising from equity-settled share-based payment transactions | €   € 8,035   € 5,658 704
Share-based payment expenses | €   € 8,035   5,658 6,418
Equity share option 2017 (Equity settled)          
Key assumptions used to derive the option value          
Exercise price | € / shares   € 0.12      
Share price at grant date | € / shares   € 12.58      
Volatility (%)   70.00%      
Risk-free interest rate (%)   (0.70%)      
Dividend yield (%)   0.00%      
Option term (years) | Y   10      
Equity share option 2019 (Equity settled)          
Key assumptions used to derive the option value          
Exercise price | € / shares   € 12.58      
Share price at grant date | € / shares   € 12.58      
Volatility (%)   70.00%      
Risk-free interest rate (%)   (0.70%)      
Dividend yield (%)   0.00%      
Option term (years) | Y   10      
Expenses arising from share-based payment transactions          
Expenses arising from equity-settled share-based payment transactions | €   € 7,000   € 2,105 € 704
2019 Plan          
Key assumptions used to derive other equity instruments value          
Exercise price (USD)     14.00    
Share price at grant date (USD)     12.02    
Volatility (%)       75.00%  
Riskfree interest rate (%)       1.00%  
Dividend yield (%)       0.00%  
Expected contractual life (years) | Y       8.9  
Weighted average fair value (USD)     12.02    
2019 Plan | Management board and employees          
Expenses arising from share-based payment transactions          
Expenses arising from equity-settled share-based payment transactions | €   985   € 3,217  
2019 Plan | New CEO          
Expenses arising from share-based payment transactions          
Expenses arising from equity-settled share-based payment transactions | €       269  
2019 Plan | Supervisory board members          
Expenses arising from share-based payment transactions          
Expenses arising from equity-settled share-based payment transactions | €   € 50   € 67  
2019 Plan | Options          
Key assumptions used to derive other equity instruments value          
Exercise price (USD) 12.52        
Share price at grant date (USD) 12.54        
Volatility (%)   75.00%      
Riskfree interest rate (%)   1.90%      
Dividend yield (%)   0.00%      
Expected contractual life (years) | Y   10      
Weighted average fair value (USD) 7.36        
2019 Plan | RSUs          
Key assumptions used to derive other equity instruments value          
Weighted average fair value (USD) $ 10.96   $ 11.62